employed 3 nm ultrasmall single-crystal iron nanoparticles as a ferroptosis inducer to synergize with 131I-PD-L1 antibodies in treating murine breast cancer cells and embryonic fibroblast cells. This evidence concerns the gene CD274 and breast cancer.